SANUWAVE Health, Inc. (SNWV)
SNWV Stock Price Chart
Explore SANUWAVE Health, Inc. interactive price chart. Choose custom timeframes to analyze SNWV price movements and trends.
SNWV Company Profile
Discover essential business fundamentals and corporate details for SANUWAVE Health, Inc. (SNWV) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
30 Sept 2009
Employees
46.00
Website
https://www.sanuwave.comCEO
Morgan C. Frank
Description
SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.
SNWV Financial Timeline
Browse a chronological timeline of SANUWAVE Health, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 7 May 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is $0.37, while revenue estimate is $12.37M.
Earnings released on 8 Aug 2025
EPS came in at $0.01 surpassing the estimated -$0.09 by +111.11%, while revenue for the quarter reached $10.16M , missing expectations by -18.84%.
Earnings released on 9 May 2025
EPS came in at -$0.66 , while revenue for the quarter reached $9.34M .
Earnings released on 20 Mar 2025
EPS came in at -$1.21 , while revenue for the quarter reached $10.33M .
Earnings released on 7 Nov 2024
EPS came in at -$6.49 , while revenue for the quarter reached $9.36M .
Stock split effective on 18 Oct 2024
Shares were split 1 : 375 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 12 Aug 2024
EPS came in at $3.70 , while revenue for the quarter reached $7.16M .
Earnings released on 9 May 2024
EPS came in at -$1.46 , while revenue for the quarter reached $5.79M .
Earnings released on 21 Mar 2024
EPS came in at $11.11 , while revenue for the quarter reached $6.99M .
Earnings released on 9 Nov 2023
EPS came in at -$3.70 , while revenue for the quarter reached $4.95M .
Earnings released on 11 Aug 2023
EPS came in at -$3.70 , while revenue for the quarter reached $4.68M .
Earnings released on 12 May 2023
EPS came in at -$7.41 , while revenue for the quarter reached $3.78M .
Earnings released on 3 Apr 2023
EPS came in at -$3.70 , while revenue for the quarter reached $5.50M .
Earnings released on 14 Nov 2022
EPS came in at $0.68 surpassing the estimated -$0.01 by +6.88K%, while revenue for the quarter reached $4.17M .
Earnings released on 15 Aug 2022
EPS came in at $3.27 surpassing the estimated -$0.01 by +32.80K%, while revenue for the quarter reached $3.88M .
Earnings released on 26 May 2022
EPS came in at -$4.96 , while revenue for the quarter reached $3.20M .
Earnings released on 13 May 2022
EPS came in at -$8.67 , while revenue for the quarter reached $4.26M , missing expectations by -47.41%.
Earnings released on 28 Feb 2022
EPS came in at -$3.08 , while revenue for the quarter reached $3.73M , missing expectations by -46.01%.
Earnings released on 14 Jan 2022
EPS came in at -$6.23 , while revenue for the quarter reached $2.91M , missing expectations by -47.11%.
Earnings released on 13 Dec 2021
EPS came in at -$3.57 surpassing the estimated -$3.75 by +4.78%, while revenue for the quarter reached $2.12M , missing expectations by -54.00%.
Earnings released on 21 Oct 2021
EPS came in at -$0.04 falling short of the estimated -$0.01 by -300.00%, while revenue for the quarter reached $1.86M , missing expectations by -38.04%.
Earnings released on 17 Nov 2020
EPS came in at -$7.41 falling short of the estimated -$3.71 by -100.00%, while revenue for the quarter reached $1.97M , beating expectations by +78.81%.
SNWV Stock Performance
Access detailed SNWV performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.